We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $3.51B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
+4.6%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$726M
AUM Growth
+$35.7M
Cap. Flow
+$4.67M
Cap. Flow %
0.64%
Top 10 Hldgs %
84.91%
Holding
84
New
3
Increased
11
Reduced
51
Closed
6
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHM icon
76
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.48B
$221K 0.03%
4,538
-18,484
-80% -$899K
IVE icon
77
iShares S&P 500 Value ETF
IVE
$48.8B
$218K 0.03%
2,418
+6
+0.2% +$530
IAU icon
78
iShares Gold Trust
IAU
$62.4B
$170K 0.02%
+6,603
New +$165K
AGG icon
79
iShares Core US Aggregate Bond ETF
AGG
$139B
-2,823
Closed -$305K
DXJ icon
80
WisdomTree Japan Hedged Equity Fund
DXJ
$7.05B
-4,235
Closed -$200K
IBM icon
81
IBM
IBM
$200B
-1,176
Closed -$216K
MS icon
82
Morgan Stanley
MS
$339B
-8,100
Closed -$252K
SPEM icon
83
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$16.9B
-11,086
Closed -$351K
MNDT
84
DELISTED
Mandiant, Inc. Common Stock
MNDT
-11,084
Closed -$682K

Similar funds

Aspiriant LLC's Q2 2014 Portfolio in Review

As of Q2 2014, Aspiriant LLC held 84 positions worth $726M, up 5.2% from $690M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Aspiriant LLC's Q2 2014 filing shows 3 new, 11 increased, 51 reduced and 6 closed positions. Its largest new stake was Wendy's: 64,196 shares worth $548K. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $1.63M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Industrials and Technology.

  • Aspiriant LLC's largest Q2 2014 buy was Wendy's: 64,196 shares worth $548K.
  • Aspiriant LLC added most to iShares Core S&P US Value ETF in Q2 2014, an estimated $8.16M increase.
  • Aspiriant LLC's biggest Q2 2014 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $1.63M.
  • Aspiriant LLC fully exited Mandiant, Inc. Common Stock in Q2 2014, selling an estimated $682K.
  • Aspiriant LLC's ten largest holdings make up 85% of its $726M portfolio in Q2 2014.
  • Aspiriant LLC opened 3 new positions and closed 6 in Q2 2014.
  • Aspiriant LLC's portfolio value rose 5.2% quarter-over-quarter to $726M.

Based on Aspiriant LLC's 13F filing for Q2 2014, filed 12 Aug 2014.